The main purpose of the IIS Programme to increase and stimulate external research into products, therapies and clinical management, coordinated by healthcare professionals with support from Wellspect.
At the core of Wellspect lies the science behind our products and the therapies they support.
We take pride in producing and delivering products that are safe, effective and accessible to our users. In addition, we are devoted to making a real difference by generating scientific research with a view of understanding the synergies between bladder and bowel management.
We conduct our own scientific research, clinical trials, and provide funding and support for Investigator Initiated Studies.
We initiated our global forum ACCT (Advancing Continence Care Together) with the aim of advancing continence care for the benefit of our users.
The first event, which took place in 2017, has been followed by both physical meetings and webinars around the globe.
Are you a nurse dedicated to helping patients with problems related to the bladder or bowel? Do you want to help patients all over the world, not only now, but also for future generations? As you know, today’s research leads to tomorrow’s clinical practice.
Wellspect’s clinical study program is developed and conducted together with leading clinicians in the field. All our studies are conducted according to Good Clinical Practice (GCP),